22 May 2013
Keywords: ista, publishes, vitrase, ph, ii, trial, results
Article | 12 September 2005
ISTA Pharmaceutical, headquartered in California, USA, has announced the publication of Phase II clinical trial results for its drug Vitrase
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 September 2005
19 September 2005
5 September 2005
© 2013 thepharmaletter.com